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Abstract 
Background: There is a marked male preponderance in autism spectrum conditions. The 
extreme male brain theory and the fetal androgen theory of autism suggest that elevated 
prenatal testosterone exposure is a key contributor to autistic traits. The current paper reports 
findings from two separate studies that test this hypothesis. Methods: A parent-report 
questionnaire, the Childhood Autism Spectrum Test (CAST), was employed to measure 
autistic traits in both studies. The first study examined autistic traits in young children with 
congenital adrenal hyperplasia (CAH), a condition causing unusually high concentrations of 
testosterone prenatally in girls. 81 children with CAH (43 girls) and 72 unaffected relatives 
(41 girls), aged 4 to 11 years, were assessed. The second study examined autistic traits in 
relation to amniotic testosterone in 92 typically-developing children (48 girls), aged 3 to 5 
years. Results: Findings from neither study supported the association between prenatal 
androgen (testosterone) exposure and autistic traits. Specifically, young girls with and 
without CAH did not differ significantly in CAST scores and amniotic testosterone 
concentrations were not significantly associated with CAST scores in boys, girls, or the 
whole sample. Conclusions: These studies do not support a relationship between prenatal 
testosterone exposure and autistic traits. These findings augment prior research suggesting no 
consistent relationship between early androgen exposure and autistic traits. Keywords: 
Congenital adrenal hyperplasia, fetal testosterone, prenatal testosterone exposure, autism, 
autistic traits, extreme male brain. 
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No Relationship Between Prenatal Androgen Exposure and Autistic Traits:        
Convergent Evidence From Studies of Children With Congenital Adrenal Hyperplasia 
and of Amniotic Testosterone Concentrations in Typically-Developing Children 
Autism Spectrum Conditions (ASCs) are neurodevelopmental conditions 
characterized by deficits in social communication and interaction, and restricted, repetitive 
patterns of behavior or interests. Although ASCs can be conceptualized as clinical conditions 
distinct from the general population, it also has been suggested that autistic traits are 
continuously distributed across the general population, with ASCs representing the upper 
extreme of the distribution (Constantino & Todd, 2003).  
There is a male preponderance in ASCs (Fombonne, 2005), with male-to-female 
ratios ranging from 4:1 for classic autism (Chakrabarti & Fombonne, 2001) to 11:1 for 
Asperger’s Syndrome (Gillberg, Cederlund,  Lamberg, & Zeijlon, 2006). In addition, males 
in the general population have been reported to exhibit more autistic traits than females 
(Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001). The extreme male brain 
(EMB) theory suggests that ASCs are an extreme manifestation of certain male-typical traits 
(Baron-Cohen, 2002). In non-human mammals, manipulations of prenatal or early postnatal 
androgen exposure permanently alter behavioral characteristics that show sex differences 
(Arnold, 2009). Similarly, androgens, such as testosterone, influence human sexual 
differentiation during fetal development and may exert enduring effects on subsequent 
gender-related behaviors (Hines, 2004). Based on this evidence, the fetal androgen theory of 
autism suggests that heightened exposure to testosterone during fetal development is a key 
mechanism underlying the EMB (Baron-Cohen, Lutchmaya, & Knickmeyer, 2004; Baron-
Cohen, Knickmeyer, & Belmonte, 2005). These two related theories, the fetal androgen 
theory of autism and the EMB theory, predict that high concentrations of testosterone 
prenatally increase autistic traits.   
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Ethical considerations preclude experimental manipulation of testosterone during 
early human development. However, some information on the influences of testosterone has 
come from individuals exposed to unusual levels of testosterone and other androgens 
prenatally due to medical conditions, such as classical congenital adrenal hyperplasia (CAH). 
CAH
1
 is an autosomal, recessive condition, occurring in approximately 1 in 16,000 to 1 in 
20,000 births (White, 2009). It is caused by an enzyme deficiency (21-hydroxylase in >90% 
of cases) that impairs cortisol production (White, 2009).  Consequently, cortisol precursors 
are shunted into the androgen pathway. Although prenatal androgen exposure varies among 
girls with CAH, partly depending on the specific genotype, androgen concentrations at mid-
gestation in girls with CAH are generally elevated to levels more characteristic of boys 
(Wudy, Dörr, Solleder, Djalali, & Homoki, 1999). Girls with CAH are usually born with 
some degree of genital virilization, leading to rapid diagnosis. They are treated postnatally 
with hormones with the goal of normalizing their androgen and cortisol concentrations, are 
usually assigned and reared as girls, and often have surgery to feminize their external 
genitalia.  Despite the early diagnosis and treatment, and female sex of rearing, they show 
more male-typical behavior in several areas, including childhood play preferences, sexual 
orientation, and gender identity (Hines, 2011). In contrast, gender-related behaviors of males 
with CAH are generally unaltered, and their androgen concentrations prenatally appear to be 
largely in the normal male range (Hines, 2011).  
One study has evaluated the hypothesis that autistic traits are increased in females 
with CAH. Knickmeyer et al. (2006) assessed autistic traits, using the Autism Spectrum 
Quotient (AQ; Baron-Cohen et al., 2001), a self-report measure, in 12-to-45-year-old 
individuals with CAH (34 females, 26 males) and their unaffected relatives (24 females, 25 
males). Unaffected males had higher AQ scores than unaffected females (Cohen’s d = 0.55, p 
                                                          
1
 In this report, CAH refers to classical CAH, unless stated otherwise.  
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< .10) and females with CAH scored higher on the AQ than unaffected females (Cohen’s d = 
0.50, p < .10). These group differences were significant only with one-tailed tests, however. 
AQ scores of males with and without CAH did not significantly differ (Cohen’s d = 0.25, p 
> .10, with higher scores in unaffected males). These findings have been interpreted to 
support the EMB theory and the fetal androgen theory of autism. 
This prior study used the AQ, a measure that was originally developed in mostly adult 
samples. It may be less appropriate for the adolescent participants in the study. It also would 
be of interest to evaluate CAH-related differences in autistic traits in young children, before 
the possible impact of the disorder and its consequences for socio-cognitive processes have 
accumulated over many years. 
A second type of investigation has related normal variability in testosterone prenatally 
to autistic traits in typically-developing children. One such approach involves measuring 
testosterone concentrations in amniotic fluid obtained during clinical amniocentesis. 
Amniocentesis is a procedure typically performed during the second trimester of pregnancy, 
coinciding with the presumed critical period for human sexual differentiation (Collaer & 
Hines, 1995). Three studies, all from one research group and all with participants drawn from 
a single pool of individuals for whom measures of amniotic testosterone were available, 
reported that amniotic testosterone correlated positively with parent-report autistic traits in 
boys and in girls (Auyeung et al., 2009, 2012; Auyeung, Taylor, Hackett, & Baron-Cohen, 
2010; see Table 1). The current report seeks to replicate this finding in an independent sample. 
-----------------------------------Insert Table 1---------------------------------- 
Both current studies extend research testing the hypothesis that prenatal androgen 
exposure predicts autistic traits. Study 1 focused on children with CAH; Study 2 examined 
amniotic testosterone and autistic traits in a sample of typically-developing children. Two 
hypotheses were evaluated: (1) girls, but not boys, with CAH show more autistic traits than 
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unaffected same-sex relatives; and (2) amniotic testosterone concentrations correlate 
positively with autistic traits in typically-developing boys and girls.  
Study 1: CAH and Autistic Traits 
Method 
Participants 
Children with CAH were recruited through a national CAH support group and 
through 11 endocrine clinics in the UK. A total of 153 children, aged 4 to 11 years (M = 7.40, 
SD = 2.30), participated. Data on participation rate as a function of numbers of contacts are 
not available. All children with CAH had classical CAH with 21-hydroxylase enzyme 
deficiency. In girls, classical CAH is characterized by excessive adrenal androgen secretion 
during fetal development, causing genital virilization and ambiguity at birth, whereas girls 
with the milder non-classical form of CAH do not show signs of prenatal androgenization 
(White, 2009). Classical CAH has two subtypes, a more severe, salt wasting subtype, and a 
less severe, simple virilizing, subtype. The simple virilizing subtype is characterized by 
genital ambiguity in affected girls. In the salt-wasting subtype, in addition to genital 
ambiguity in girls, there are sodium-deficiency symptoms in both sexes, such as dehydration 
and weight loss, resulting from inadequate secretion of salt-retaining steroids. The current 
study included 43 girls with CAH (37 salt-wasting, 6 simple-virilizing), 38 boys with CAH 
(35 salt-wasting, 3 simple-virilizing), 41 unaffected female relatives (31 sisters, 9 first 
cousins, 1 adopted sister), and 31 unaffected male relatives (23 brothers, 8 first cousins). 
Diagnostic information was obtained from medical background interviews with parents and 
confirmed by information on medications being taken. None of the children had been treated 
prenatally with dexamethasone, a glucocorticoid that is sometimes used to treat pregnancies 
where CAH is suspected, and which can reduce physical virilization.  
Of the 153 children, 137 were Caucasian, 1 was Mid-Eastern, 5 were 
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Indian/Bangladeshi, 1 was African/Afro-Caribbean, 8 were mixed race, and 1 was of other 
descent. The majority (96.1%) of the children came from two-parent families; 3.9%lived with 
their mother only. Regarding parental education, 22.9% of the children had parents with no 
post-secondary education; 60.8% had at least one parent with vocational training/ university 
degree; 16.3% had at least one parent with postgraduate education. There were no significant 
differences among the four groups in ethnicity, family structure, or parental education (χ2 = 
3.59–10.29, p = .66–.80). 
Procedures and Measures 
Assessment procedures were 3 to 4 hours long and included measures of a range of 
gender-related outcomes. Data for other measures have been (Browne et al., 2015; Hines et 
al., 2016; Pasterski et al., 2015), or will be, reported separately. The data reported here are the 
only data that were collected on autistic traits. The participants were blind to the study 
hypotheses. Parents provided informed consent for their own and their child’s participation in 
the study. The study protocols were approved by national and institutional research ethics 
committees. 
Autistic Traits. The Childhood Autism Spectrum Test (CAST; Scott, Baron-Cohen, 
Bolton, & Brayne, 2002) is a 37-item parent-report questionnaire developed to detect ASCs 
in children ages 4 to 11 years. CAST items require a binary response (‘yes/no’) to 37 
questions, 31 of which are scored. For these 31 items, an ASC-positive response scores 1 and 
an ASC-negative response scores 0. Some items are reverse scored so that not all ‘yes’ 
responses score 1. The remaining 6 items are control questions and are not scored. The CAST 
has good test–retest reliability (r = .83) after 2 weeks (Williams et al., 2006). A score of 15 or 
above indicates risk for ASCs (Scott et al., 2002; Williams et al., 2005). At that cut-point, the 
CAST has high specificity (97%) and sensitivity (100%) for ASCs (Williams et al., 2005).  
For 96% of the children, mothers completed the CAST; for 4%, fathers completed it. A 
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CAST score was not available for 1 girl with CAH. Internal consistency of the items, as 
indicated by Cronbach's α coefficient, was good (α = .76)  
Control Variables. The age of the child at the time of testing was recorded. Also, the 
vocabulary subtest of the Wechsler Intelligence Scale for Children (4th ed.) (WISC-IV) 
(Wechsler, 2003) or the Wechsler Preschool and Primary Scale of Intelligence (3rd ed.) 
(WPPSI-III) (Wechsler, 2002), as age appropriate, provided estimates of general intelligence. 
Age-scaled vocabulary scores were used for analyses, and were available for all children. 
Data Analyses 
The distributions of CAST scores were positively skewed. Following Auyeung et al. 
(2009), CAST scores were transformed by adding one and taking the square root of each 
score. This transformation produced distributions that were not significantly skewed in the 
overall sample or within either sex. Analyses were based on the transformed scores unless 
otherwise stated.  All analyses were two-tailed with alpha set at .05. Descriptive statistics for 
CAST scores, age, and vocabulary for individual groups and the overall sample are reported 
in Table 2.  
-----------------------------------Insert Table 2--------------------------------- 
Results 
There were no significant group differences in age or vocabulary (age: F(3, 149) = 
0.79, p = .51; vocabulary: F(3, 149) = 1.11, p = .35). CAST scores were not significantly 
associated with age, r(150) = -.05, p = .58, but were significantly associated with vocabulary, 
r(150) = -.24, p < .01.  
The regression model with sex, CAH status, interaction between sex and CAH status, 
and vocabulary scores entered as predictors of CAST scores was significant, R² = .08, F(4, 
147) = 3.19, p < .05. Vocabulary was a significant negative predictor, B = -0.05, SE = .02, p 
< .01, but sex, CAH status, and the interaction between sex and CAH status were not 
Running head: PRENATAL ANDROGEN EXPOSURE AND AUTISTIC TRAITS     9 
 
 
significant (p = .29–.67), and remained non-significant when vocabulary was removed from 
the model (p =.15–.87). 
To further examine the association between CAST scores and CAH, and allow direct 
comparison to Knickmeyer et al. (2006), independent samples t-tests and Cohen’s ds were 
computed. Positive values indicate higher scores in boys or individuals with CAH. There was 
no significant difference in CAST scores between boys and girls without CAH, t(70) = -0.52, 
p = .61, d = -0.12, girls with and without CAH, t(81) = 1.36, p = .18, d = 0.30, boys with and 
without CAH, t(67) = 1.65, p = .103, d = 0.39, or boys and girls with CAH, t(78) = -0.34, p 
= .74, d = -0.08. The above analyses were repeated using original CAST scores, with highly 
comparable results and similar effect sizes as in the initial analyses.  
Three children with CAH (1 boy, 2 girls) and 3 unaffected relatives (1 boy, 2 girls) 
scored at or above the cut-off of 15 on the CAST. There were no significant group 
differences in having a CAST score of 15 or above (Fisher’s exact p =.46–1.00). 
Study 2: Amniotic Testosterone and Autistic Traits 
Method 
Participants 
This study included 92 children (48 girls, 44 boys), between 3 and 5 years of age (M 
= 4.27, SD = .33), whose mothers underwent amniocentesis for clinical purposes at Imperial 
College, NHS Trust. Invitations to participate in this study were sent to 107 parents, and 92 
(86%) participated. A pediatrician confirmed all children as healthy at birth. Of the 92 
children, 62 were Caucasian, 4 were Mid-Eastern, 7 were Indian/Bangladeshi, 5 were 
African/Afro-Caribbean, 13 were mixed race, and 1 was of other descent. Most children 
(90.2%) came from two-parent families; 9.8% lived with their mother only. Regarding 
parental education, 7.6% of the children had parents with no post-secondary education; 
59.8% had at least one parent with vocational training/ university degree; 32.6% had at least 
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one parent with postgraduate education. Boys and girls did not differ significantly in ethnicity, 
family structure, or parental education (χ2 = 0.52–6.12, p = .26–.77).   
Procedures and Measures 
Amniotic Testosterone. Amniocentesis was performed between 15 and 25 weeks of 
gestation (M = 16.93, SD = 2.01), coinciding with the presumed critical period for human 
sexual differentiation (Collaer & Hines, 1995; Hines, 2004). All amniotic fluid samples were 
taken in the morning between 9:30 am and 12:30 pm. An aliquot of up to 4 mL of amniotic 
fluid surplus to clinical requirement was drawn for the study and stored at -80°C until assay. 
Total testosterone was assayed by radioimmunoassay using the “Coat-A-Count” method 
(Coat-A-Count, DPC, Los Angeles, California), after solvent extraction and concentration. 
The intra- and inter-assay coefficients of variation of the amniotic fluid testosterone assay 
were 7.5% and 8.9%, respectively. Amniocentesis is typically performed with mothers whose 
children are at risk of genetic abnormalities associated with increased maternal age. Mothers 
had a mean age of 37.3 years (SD = 4.05) at their child’s birth. Boys and girls did not differ 
significantly in gestational age at amniocentesis or maternal age at birth (t = 0.14–0.40, p 
= .69–.99). 
Other procedures and measures were identical to those for study 1 (CAH), with the 
following exceptions. In study 2, CAST scores were not available for 1 boy, Cronbach’s 
alpha for the CAST was 0.67, and vocabulary scores were not available for 3 boys and 1 girl. 
Data analyses  
Distributions of CAST scores were positively skewed and were transformed as 
described for Study 1 with the same results. Distributions of amniotic testosterone 
concentrations were also positively skewed and were transformed by adding one and taking 
the log of each value. These transformations resulted in distributions that were not 
significantly skewed in the overall sample or within either sex. As in Study 1, reported 
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analyses are based on transformed scores unless otherwise stated, and all analyses were two-
tailed, with α set at .05. Descriptive statistics for amniotic testosterone concentrations, CAST 
scores, age, and vocabulary within each sex and for the overall sample, and effect sizes 
(Cohen’s d) for differences between boys and girls in these variables are reported in Table 3. 
-----------------------------------Insert Table 3--------------------------------- 
Results 
There was no significant gender difference in age or vocabulary (age: t(90) = 1.09, p 
= .28; vocabulary: t(86) = -1.66, p = .10). CAST scores were not significantly associated with 
age, r(89) = -.16, p = .14, but were significantly associated with vocabulary, r(86) = -.23, p 
< .05. 
Independent samples t-tests showed that boys had significantly higher concentrations 
of amniotic testosterone, t(65.07) = 10.64, p < .001, equal variances not assumed, and 
significantly higher CAST scores, t(89) = 2.07, p < .05, than girls. Amniotic testosterone was 
not significantly correlated with CAST scores in boys, r(41) = -.05, p = .73, or girls, r(46) = -
.10, p = .48, or in boys and girls combined, r(89) = .11, p = .28
2
. When vocabulary scores 
were taken into account in a multiple regression model, the association between amniotic 
testosterone and CAST scores remained non-significant within each sex and for the entire 
sample (p = .54–.72).  
The above analyses were repeated after excluding children under the age of 4 years (4 
boys and 4 girls aged 3.81 to 3.99 years) because the CAST was developed and validated in a 
sample of children aged 4 to 11 years (Scott et al., 2002). Analyses were also repeated using 
original CAST scores and amniotic testosterone concentrations. Highly comparable results 
were found, showing similar effect sizes for associations between amniotic testosterone and 
autistic traits as in the initial analyses.  
                                                          
2
 The direction of the correlation changed when data from boys and girls were analyzed together, probably 
because boys had higher CAST scores and higher amniotic testosterone concentrations than girls.  
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One boy and no girls scored at or above the cut-off score of 15 on the CAST. Within 
the male group, the amniotic testosterone concentration of that high-scoring participant was 
slightly above the mean, at the 54
th
 percentile. 
Discussion 
The EMB theory and the fetal androgen theory of autism propose that exposure to 
high concentrations of testosterone prenatally contributes to elevated autistic traits and to 
ASCs (Auyeung et al., 2009, 2010, 2012; Baron-Cohen, 2002; Baron-Cohen et al., 2004, 
2005). This hypothesized effect of testosterone on autistic traits was investigated in the two 
studies reported here. The first study included children with CAH and their unaffected 
relatives, and provided the first test of autistic traits in young children with CAH, a 
potentially valuable group for testing the hypothesis that prenatal androgen exposure 
influences autistic traits. In this study, there was no significant difference in autistic traits 
between children with and without CAH for either girls or boys. The second study focused on 
typically-developing children whose mothers underwent amniocentesis during pregnancy, 
which is generally thought to provide relevant data on testosterone for testing the study 
hypotheses. In this study, amniotic testosterone was not significantly related to autistic traits 
in either boys or girls. In both studies, having an autistic traits score that indicated a risk of an 
ASC was not significantly associated with heightened exposure to testosterone prenatally. 
These findings do not support the hypotheses that prenatal testosterone contributes to autistic 
traits or to ASCs.  
Autistic Traits in Children With CAH 
Although there was a trend for girls with CAH to score higher on the autistic traits 
measure than unaffected girls in the current study, the group difference in the current study 
(Cohen’s d = 0.30; M = 6.76, SD = 3.76 in girls with CAH; M = 5.76, SD = 4.31 in 
unaffected girls) was smaller than that in the previous study of older females with CAH 
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(Cohen’s d = 0.50; M = 18.44, SD = 5.51 in females with CAH; M = 16.00, SD = 4.25 in 
unaffected females). There was also a trend for boys with CAH to score higher than 
unaffected boys on the autistic traits measure in the current study (Cohen’s d = 0.39; M = 
6.42, SD = 3.39 in boys with CAH; M = 5.16, SD = 3.28 in unaffected boys). By contrast, in 
the previous study, the trend suggested higher scores in unaffected males than males with 
CAH (Cohen’s d = 0.25; M = 17.35, SD = 6.05 in males with CAH; M = 18.88, SD = 6.21 in 
unaffected males). The slightly, and non-significantly, elevated scores in both boys and girls 
with CAH in the current study are unlikely to be attributable to prenatal androgen exposure, 
because only girls, and not boys, with CAH are exposed prenatally to higher than normal 
androgen concentrations (Wudy et al., 1999).  
These inconsistent findings may be explained by methodological differences between 
the studies. The study of Knickmeyer et al. (2006) used a self- report measure that may not 
have been sufficiently sensitive for adolescent participants, perhaps because an age-
appropriate measure was not then available. The ages of participants in the two studies also 
differed in ways that could have produced different results. The current child sample is 
substantially younger than the adolescent and adult sample used by Knickmeyer et al. (2006). 
It is possible that autistic traits, particularly those related to social communication and 
interaction, may change as individuals with CAH become older; if so, the differing findings 
between the studies could result from the different ages studied.  The younger age in the 
current study may provide a more direct assessment of the effects of prenatal androgen 
exposure, because there would have been less time for postnatal influences. 
Amniotic Testosterone and Autistic Traits in Typically-developing Children 
Prior studies (Auyeung et al., 2009, 2010, 2012) generally reported significant 
positive correlations between amniotic testosterone and autistic traits in both typically-
developing boys (r = .22–.51) and girls (r = .08–.57). In contrast to prior studies and the 
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hypothesized direction of effect, the current study found a non-significant negative 
correlation in boys (r = -.05) and girls (r = -.10).  
The one prior study that related amniotic testosterone to autistic traits assessed using 
the CAST, the same measure used in the current study, found a significant correlation in boys 
but not in girls (Auyeung et al., 2009). That same study found positive correlations for both 
boys and girls between testosterone and scores on a different measure, the AQ-Child. The 
convergent validity between the CAST and the AQ-Child has been reported to be weak (r 
= .25; Auyeung et al., 2009), despite both measures having been psychometrically validated 
for assessment of autistic traits, with high sensitivity, specificity, and test-retest reliability 
(Auyeung et al., 2008; Williams et al., 2005, 2006). The implication is that the association 
between amniotic testosterone and measures of autistic traits is not robust.   
While the current findings contradict previous research on amniotic testosterone and 
autistic traits, and CAH and autistic traits, they are consistent with the recent finding of no 
difference in amniotic testosterone concentrations between 128 males diagnosed with ASCs 
and 217 matched male controls (Baron-Cohen et al., 2015). Although Baron-Cohen et al. 
(2015) also reported that scores of a latent factor representing shared variance of five 
amniotic hormones (progesterone, 17α-hydroxy-progesterone, androstenedione, testosterone 
and cortisol) were significantly higher in the ASC group than the comparison group, it is 
unclear whether this latent hormonal factor is related to processes of sexual differentiation, 
given no evidence that it differs for males and females. 
Early Androgen Exposure and Autistic Traits 
The findings from the two current studies also appear to concur with previous 
research examining the link between perinatal or early postnatal androgen exposure and 
autistic traits in non-clinical samples. Although the EMB theory and the fetal androgen theory 
of autism focus on the role of prenatal androgen exposure (Baron-Cohen, 2002; Baron-Cohen 
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et al., 2004, 2005), studies of non-human mammals suggest that both prenatal and early 
postnatal androgen exposure contribute to neurobehavioral sexual differentiation (Arnold, 
2009). Two prior studies, based on a longitudinal pregnancy cohort of around 400 individuals, 
found no relationship in either sex between perinatal androgen exposure, assessed by 
concentrations of hormones in umbilical cord blood samples collected at birth, and autistic 
traits in early adulthood, assessed by a self-report questionnaire (Jamnadass et al., 2015; 
Whitehouse et al., 2012). However, androgen concentrations in umbilical cord blood at birth 
can be influenced by the type of delivery and by labor, and may reflect androgen exposure 
during late gestation (Keelan et al., 2012), after the prenatal testosterone surge in male fetuses 
during the presumed critical period for human sexual differentiation (Collaer & Hines, 1995).  
In addition to the prenatal surge, testosterone is elevated in male infants during the 
early postnatal period called “mini-puberty”, with testosterone concentrations peaking at 
around 1 to 3 months postnatal before declining to low childhood values by around 6 months 
of age (Winter et al., 1976). Two prior studies found little to no association between salivary 
testosterone at 3 to 4 months postnatal and subsequent parent-report autistic traits in toddlers 
(N = 35 in Auyeung et al., 2012; N = 84 in Saenz & Alexander, 2013). A more recent study 
related salivary testosterone during the peak of mini-puberty at 1 to 3 months of age to 
subsequent parent-report autistic traits and also found no relationship in either sex in a sample 
of 86 toddlers (Kung, Constantinescu, Browne, Noorderhaven, & Hines, 2016). Although 
these studies had relatively small samples, they converge to suggest that there is little to no 
association between testosterone exposure during mini-puberty and autistic traits.  
Limitations 
Although boys and girls in the current amniotic testosterone study differed as 
expected in CAST scores, unaffected boys and girls in the current CAH study did not. This 
lack of a consistent gender difference on the measure of autistic traits might reduce the 
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theoretical basis for predicting a relationship to testosterone, because effects of testosterone 
are generally limited to outcomes that show gender differences. Nevertheless, the CAST has 
been validated as a measure of autistic traits and of risk for ASCs, and so both the lack of a 
gender difference and the lack of a relationship to testosterone argue against androgens 
causing autistic traits. More generally, not many studies have reported on gender differences 
in autistic traits measured by the CAST or by other parent-report autistic traits measures for 
children (e.g., Allison et al., 2008; Auyeung et al., 2009; Williams et al., 2008), and thus 
information regarding the magnitude and the reliability of these gender differences is limited.  
As with previous research, the current research is limited by using amniotic 
testosterone concentrations as a measure of normal variability in prenatal androgen exposure. 
Participants undergoing amniocentesis may not be representative of the general population, 
although we only followed up individuals without clinical findings or abnormal birth 
outcomes. Also, the reliability of amniotic testosterone as an index of prenatal androgen 
exposure may be limited, because only a single amniotic fluid sample is collected, usually 
uncontrolled for time of day or gestational age, although in the current study time of day was 
controlled to some extent by taking all amniotic fluid samples in the morning. While it is 
often assumed that testosterone concentrations in amniotic fluid are a proxy for testosterone 
concentrations in fetal blood (Baron-Cohen et al., 2004), the one study that has investigated 
their relationship found no correlation between the two (Rodeck, Gill, Rosenberg, & Collins, 
1985).  
Finally, we conducted two studies on relatively small groups of children. Nevertheless, 
the sample in our CAH study is larger than that in the previous CAH study and the sample in 
our amniotic testosterone study is larger than that in the previous amniotic testosterone study 
showing the biggest effects. More importantly, the directions of the current effects do not 
support the hypothesized relationship.  
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Conclusion 
Previous research relating prenatal testosterone exposure to autistic traits has been 
interpreted to support the EMB theory and the fetal androgen theory of autism, but 
convergent findings from the two current studies of children with CAH and amniotic 
testosterone concentrations in typically-developing children suggest that the hypothesized 
relationship may not be reliable or robust, especially in young children. On a broader level, 
the current studies augment information from studies using different measures and study 
populations to assess the influences of prenatal, perinatal, or early postnatal androgen 
exposure on autistic traits. This body of evidence suggests there is no consistent relationship 
between early androgen exposure and autistic traits. 
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Key Points 
1. Some prior research suggests that prenatal androgen exposure contributes to autistic traits.  
2. First study on autistic traits in young children with congenital adrenal hyperplasia. 
3. Autistic traits were not elevated in girls or boys with congenital adrenal hyperplasia. 
4. Amniotic testosterone did not relate to autistic traits in typically-developing boys or girls.  
5. Results from two studies converge to argue against testosterone causing ASCs. 
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Table 1  
Previous Studies on Amniotic Testosterone and Autistic Traits in Typically-Developing Children 
Study Sample size  Age  Measure Cohen’s d for gender 
differences in autistic 
traits
1
 
Correlation between 
amniotic testosterone and 
autistic traits  
Auyeung et al. (2009) 118 boys, 117 girls M = 8.91 years  
SD = 0.95 year    
Range = 6–10 years  
The Childhood Autism Spectrum 
Quotient (AQ-Child; Auyeung, Baron-
Cohen, Wheelwright, & Allison, 
2008) 
The Childhood Autism Spectrum Test 
(CAST; Scot, Baron-Cohen, Bolton, & 
Brayne, 2002)  
AQ:  
d = 0.87*** 
 
 
CAST:  
d = 0.30*  
AQ:  
r = .22*** in boys  
r = .27*** in girls  
r = .41*** in all children 
CAST:  
r = .28*** in boys
2
 
r = .08
ns
     in girls
2
 
r = .25*** in all children 
Auyeung, Taylor, 
Hackett, & Baron-
Cohen, (2010) 
66 boys, 63 girls M = 19.25 months 
SD = 1.52 months 
Range = 18–24 months 
The Quantitative Checklist for Autism 
in Toddlers (Q-CHAT; Allison et al., 
2008) 
d = 0.46* r = .36* in boys  
r = .31* in girls  
r = .40** in all children 
Auyeung et al. (2012)  15 boys, 20 girls M = 19.34 months 
SD = 2.93 months 
Range = 18–35 months  
The Quantitative Checklist for Autism 
in Toddlers (Q-CHAT; Allison et al., 
2008) 
d = 0.92** 
  
r = .51* in boys 
r = .57* in girls 
r = .56** in all children 
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1
Positive d values indicate higher scores in males. 
2
Sizes of the correlation coefficients were not reported in Auyeung et al. (2009) but were provided in Auyeung (2008).  
*p < .05. **p < .01. ***p < .001. 
ns
non-significant (p > .05). All tests were two-tailed.  
 
Running head: PRENATAL ANDROGEN EXPOSURE AND AUTISTIC TRAITS     26 
 
 
Table 2  
Study 1 Statistics: Means (Ms) and Standard Deviations (SDs) of Original Childhood Autism Spectrum Test (CAST) Scores, Age and Age-Scaled Vocabulary 
Scores in Boys and Girls With and Without Congenital Adrenal Hyperplasia (CAH) and in the Overall Sample 
 CG  CB  CAHG  CAHB  Overall 
 n M (SD)  n M (SD)  n M (SD)  n M (SD)  n M (SD) 
CAST  41 5.76 (4.31)  31 5.16 (3.28)  42 6.76 (3.76)  38 6.42 (3.39)  152 6.07 (3.75) 
Age (years) 41 7.59 (2.51)  31 7.81 (2.36)  43 7.13 (2.28)  38 7.15 (2.04)  153 7.40 (2.30) 
Vocabulary   41 11.32 (2.90)  31 10.84 (2.56)  43 10.16 (3.32)  38 10.82 (2.72)  153 10.77 (2.92) 
Note. CG, control girls; CB, control boys; CAHG, girls with CAH; CAHB, boys with CAH.  
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Table 3 
Study 2 Statistics: Means (Ms) and Standard Deviations (SDs) of Original Amniotic Testosterone Concentrations, Original Childhood Autism Spectrum 
(CAST) Scores, Age and Age-Scaled Vocabulary Scores Within Each Sex and in the Overall sample, and Cohen’s ds for Differences Between Boys and Girls 
 Boys (B)  Girls (G)  Overall  B vs. G 
 n M (SD)  n M (SD)  n M (SD)  d 
Amniotic testosterone (nmol/L) 44 0.83 (0.41)  48 0.23 (0.15)  92 0.52 (0.43)  1.98 
CAST  43 6.49 (3.59)  48 5.14 (2.47)  91 5.78 (3.11)  0.44 
Age (years)  44 4.31 (0.37)  48 4.23 (0.29)  92 4.27 (0.33)  0.24 
Vocabulary  41 10.46 (2.70)  47 11.34 (2.27)  88 10.93 (2.50)  -0.35 
Note. Positive d values indicate higher values in males.  
 
